ABSTRACT
Introduction diabetic retinopathy remains the mainly cause of blindness worldwide and its diagnoses and assessment is poorer as the countryside the patient is. To minimize de boundaries of health care and improve the accuracy how the treatment is stablished, the artificial intelligence (AI) techniques have been studied years ago using fundus phothographies for instance. This scoping review aims to study these AI techniques applied in Opctical Coherence Tomography (OCT) images.
Methods This scoping review will follow the methodology framework defined in “Scoping studies: advancing the methodology”. In this methodological framework, six stages are proposed for scoping review
Studies identifying the research question; identifying relevant studies; study selection; charting the data; collating, summarizing, and reporting the results; and consultation. The research questions aim to investigate what are the methods, and techniques used in artificial intelligence due to perfmorm a clinical diagnostic using OCT scanners. The team will focus on the Scopus Document Search e PubMed (Medline). The search query is a combination of terms related to Diabetic Retinopathy AND Artificial Intelligence.
Ethics and Dissemination This is a scoping review study and there is no requirement for ethical approval, as primary data will not be collected. The results from this scoping review will be published in a peer reviewed journal and reported at scientific meetings. We intend to share the results with the Ophthalmologists.
Strengths and Limitations of this study This protocol uses a comprehensive approach, relating one research question, that will enable the identification of the main gaps and opportunities in the area;
Due to the comprehensiveness of this review protocol, it can serve as the basis for future works, with more specific scope, and the proposal of standards;
The investigation of who are the mainly artificial intelligence skills will allow other researchs in this area;
The inclusion of aspects of data governance in the protocol will serve as the basis for establishing an assessment model of artificial intelligence and diabetic macular thickness;
One weakness of this review protocol was the number of the studies including glaucoma in their criterias.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
IT WASN'T SPONSORED
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
THERE WASN'T PATIENTS ENROLLED.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
